Invesaro

Stocks Health care GUTS

NASDAQ · Health care

Fractyl Health, Inc. (GUTS)

It posted a net loss of $105.7M. In fiscal 2025 capital spending exceeded operating cash flow by $90.9M. At June 30, 2026 it held $47.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.

Free, no password. An email when GUTS files with the SEC.

Price
$0.90
-3.52% on the day · November 9, 2026
52-week range $0.82 to $29.34
Market cap
$142.8M

Key facts about Fractyl Health, Inc.

Net worth
Fractyl Health, Inc. has a market value (market cap) of $142.8M at the latest share price, and shareholders' equity of -$1.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $0 (-100.0% year on year), with a net loss of $141M.
Cash flow
In fiscal 2025 operations used $90.3M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 10, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Fractyl Health, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Fractyl Health, Inc. does

Fractyl Health, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker GUTS.

Revenue and profit by year

Revenue
FY24: $120K $120K FY24FY24: $93K $93K FY24FY25: $0 $0 FY25
Net income
FY24: -$77.1M -$77.1M FY24FY24: -$68.7M -$68.7M FY24FY25: -$141M -$141M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$0-$96.8M-$141M-$1.86-$90.9M
2024$93K-$93.5M-$68.7M-$1.62-$67.3M
2024$120K-$50.8M-$77.1M-$45.29-$43.2M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around November 11, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 12, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Latest SEC filings

What Fractyl Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 1, 2026
  2. September 24, 2026
  3. September 11, 2026
  4. August 24, 2026
  5. August 14, 2026
  6. August 10, 2026
    Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$0.16 versus -$0.57.
  7. August 10, 2026
  8. July 15, 2026
  9. June 11, 2026
  10. June 4, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 16, 2026. Insider transactions on SEC

Insider trades

What the people running Fractyl Health, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $39.9K worth of shares on the open market in the last 90 days and sold none.

Bought (open market)
$39.9K
last 90 days
Sold
$0
last 90 days
Net bought
64,516
$39.9K
DateInsiderWhatSharesPriceValueFiling
September 14, 2026 Bradley WilliamDirector Bought 64,516 $0.62 $39.9K Form 4
June 12, 2026 Royan AjayDirector Bought 23,000 $0.85 $19.6K Form 4
June 10, 2026 Rajagopalan HarithChief Executive Officer, Director Bought 25,000 $0.73 $18.3K Form 4
June 10, 2026 Sheffield IanDirector Bought 35,000 $0.73 $25.5K Form 4
June 10, 2026 Bradley WilliamDirector Bought 68,493 $0.73 $50.3K Form 4
June 8, 2026 Smith Weber LaraChief Financial Officer Bought 20,000 $0.69 $13.7K Form 4
December 4, 2025 Rajagopalan HarithChief Executive Officer, Director Bought 10,416 $1.92 $20K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns GUTS

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Nantahala Capital Management, LLC13G, passive with 2 related filers 9.99% 16,124,780 May 15, 2026
Deer VII & Co. L.P.13G, passive with 4 related filers 9.9% 4,770,901 February 14, 2025

Latest filings below 5%: 683 Capital Management, LLC 4.81% (May 15, 2026); SilverArc Capital Management, LLC 2.3% (May 13, 2026); Alyeska Investment Group, L.P. 4.97% (February 17, 2026); Ajay Royan 4.7% (February 12, 2026); Cvf, LLC 3.4% (February 4, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 76 managers reported a position.

HolderSharesValueChange on quarter
Nantahala Capital Management, LLC22,578,192$17.9M+9,213,673
Catalio Capital Management, LP6,168,749$4.9M+676,883
Vanguard Capital Management LLC6,096,926$4.8M+563,920
Bank of America Corp6,034,147$4.8M+5,909,158
Pale Fire Capital SE5,003,237$4M-917,808
General Catalyst Group Management, LLC4,884,186$3.9M-7
Deer Management Co. LLC4,770,901$3.8M0
Maverick Capital Ltd3,974,806$3.2M0
M28 Capital Management LP1,856,117$1.5M0
BlackRock, Inc.1,801,060$1.4M-338,777
Woodline Partners LP1,783,592$1.4M-458,087
Jane Street Group, LLC1,731,622$1.4M+1,691,913
Silverarc Capital Management, LLC1,637,976$1.3M-63,649
UBS Group AG1,579,889$1.3M-42,274
CM Management, LLC1,400,000$1.1M0
Geode Capital Management, LLC1,316,341$1M-118,920
Ikarian Capital, LLC1,100,000$873.8K0
Marshall Wace, Llp1,080,667$853.7K+272,871
Logos Global Management LP1,000,000$794.4K0
Brevan Howard Capital Management LP916,321$719.3K+683,952

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

5 insiders reported holding 785,596 shares in total, about $704.8K at the last price.

HolderSharesAs of
Rajagopalan HarithChief Executive Officer, Director 540,557 June 10, 2026
Bradley WilliamDirector 149,138 September 14, 2026
Royan AjayDirector 40,901 June 12, 2026
Sheffield IanDirector 35,000 June 10, 2026
Smith Weber LaraChief Financial Officer 20,000 June 8, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about GUTS

What does Fractyl Health, Inc. do?

Fractyl Health, Inc. is a company in the Health care sector, listed on NASDAQ as GUTS. Its shares trade on NASDAQ under the ticker GUTS.

What is Fractyl Health, Inc.'s net worth?

Fractyl Health, Inc. has a market value (market cap) of $142.8M at the latest share price, and shareholders' equity of -$1.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Fractyl Health, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $105.7M.

When did Fractyl Health, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the bylaws or fiscal year changed from October 1, 2026.

When is Fractyl Health, Inc.'s next earnings report?

Fractyl Health, Inc.'s next report is expected around November 11, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare GUTS with

Compare GUTS with any company

Follow GUTS

Get an email when Fractyl Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when GUTS files with the SEC.

Where the numbers come from

Financial figures are the values Fractyl Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.